🚀 VC round data is live in beta, check it out!
Haier Biomedical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Haier Biomedical and similar public comparables like UFP Technologies, Nihon Kohden, Oxford Nanopore Technologies, Nolato and more.
Haier Biomedical Overview
About Haier Biomedical
Qingdao Haier Biomedical Co Ltd is engaged in designing, manufacturing, marketing and sales of low temperature storage equipment for biomedical samples. The company provides provides complete storage solutions for biological sample banks, blood safety, vaccine safety, medical supplies and reagent safety.
Founded
2005
HQ
Employees
N/A
Website
Financials (FY)
EV
$1B
Haier Biomedical Financials
Haier Biomedical reported last fiscal year revenue of $341M and EBITDA of $58M.
In the same fiscal year, Haier Biomedical generated $160M in gross profit, $58M in EBITDA, and $37M in net income.
Revenue (LTM)
Haier Biomedical P&L
In the most recent fiscal year, Haier Biomedical reported revenue of $341M and EBITDA of $58M.
Haier Biomedical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $341M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $160M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 47% | XXX | XXX | XXX |
| EBITDA | — | XXX | $58M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 17% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 10% | XXX | XXX | XXX |
| Net Profit | — | XXX | $37M | XXX | XXX | XXX |
| Net Margin | — | XXX | 11% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Haier Biomedical Stock Performance
Haier Biomedical has current market cap of $2B, and enterprise value of $1B.
Market Cap Evolution
Haier Biomedical's stock price is $4.92.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $2B | 0.0% | XXX | XXX | XXX | $0.12 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHaier Biomedical Valuation Multiples
Haier Biomedical trades at 4.0x EV/Revenue multiple, and 23.9x EV/EBITDA.
EV / Revenue (LTM)
Haier Biomedical Financial Valuation Multiples
As of April 20, 2026, Haier Biomedical has market cap of $2B and EV of $1B.
Equity research analysts estimate Haier Biomedical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Haier Biomedical has a P/E ratio of 42.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 4.0x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 23.9x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 40.2x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 8.6x | XXX | XXX | XXX |
| P/E | — | XXX | 42.3x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 63.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Haier Biomedical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Haier Biomedical Margins & Growth Rates
Haier Biomedical's revenue in the last fiscal year grew by 2%.
Haier Biomedical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 17% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (25%) | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 7% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 14% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 37% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Haier Biomedical Public Comps
See public comps and valuation multiples for other Laboratory Services and Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Haier Biomedical | XXX | XXX | XXX | XXX | XXX | XXX |
| UFP Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| Nihon Kohden | XXX | XXX | XXX | XXX | XXX | XXX |
| Oxford Nanopore Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| Nolato | XXX | XXX | XXX | XXX | XXX | XXX |
| Pulse Biosciences | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Haier Biomedical M&A Activity
Haier Biomedical acquired XXX companies to date.
Last acquisition by Haier Biomedical was on XXXXXXXX, XXXXX. Haier Biomedical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Haier Biomedical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialHaier Biomedical Investment Activity
Haier Biomedical invested in XXX companies to date.
Haier Biomedical made its latest investment on XXXXXXXX, XXXXX. Haier Biomedical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Haier Biomedical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Haier Biomedical
| When was Haier Biomedical founded? | Haier Biomedical was founded in 2005. |
| Where is Haier Biomedical headquartered? | Haier Biomedical is headquartered in China. |
| Is Haier Biomedical publicly listed? | Yes, Haier Biomedical is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of Haier Biomedical? | Haier Biomedical trades under 688139 ticker. |
| When did Haier Biomedical go public? | Haier Biomedical went public in 2019. |
| Who are competitors of Haier Biomedical? | Haier Biomedical main competitors are UFP Technologies, Nihon Kohden, Oxford Nanopore Technologies, Nolato. |
| What is the current market cap of Haier Biomedical? | Haier Biomedical's current market cap is $2B. |
| What is the current revenue of Haier Biomedical? | Haier Biomedical's last fiscal year revenue is $341M. |
| What is the current EV/Revenue multiple of Haier Biomedical? | Current revenue multiple of Haier Biomedical is 4.0x. |
| Is Haier Biomedical profitable? | No, Haier Biomedical is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.